Growth Metrics

Cellebrite DI (CLBT) Other Non-Current Liabilities (2020 - 2025)

Cellebrite DI's Other Non-Current Liabilities history spans 6 years, with the latest figure at $16.7 million for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 139.82% to $16.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.7 million through Dec 2025, up 139.82% year-over-year, with the annual reading at $16.7 million for FY2025, 139.82% up from the prior year.
  • Other Non-Current Liabilities came in at $16.7 million for Q4 2025, up from $7.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $54.1 million in Q4 2023 to a low of $5.0 million in Q2 2023.
  • The 5-year median for Other Non-Current Liabilities is $6.6 million (2022), against an average of $9.8 million.
  • Year-over-year, Other Non-Current Liabilities skyrocketed 903.28% in 2023 and then plummeted 87.15% in 2024.
  • Cellebrite DI's Other Non-Current Liabilities stood at $9.5 million in 2021, then crashed by 43.44% to $5.4 million in 2022, then surged by 903.28% to $54.1 million in 2023, then tumbled by 87.15% to $7.0 million in 2024, then skyrocketed by 139.82% to $16.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Other Non-Current Liabilities are $16.7 million (Q4 2025), $7.5 million (Q3 2025), and $6.9 million (Q2 2025).